147 related articles for article (PubMed ID: 17109186)
1. HBcAg-specific CD4+CD25+ regulatory T cells modulate immune tolerance and acute exacerbation on the natural history of chronic hepatitis B virus infection.
Feng IC; Koay LB; Sheu MJ; Kuo HT; Sun CS; Lee C; Chuang WL; Liao SK; Wang SL; Tang LY; Cheng CJ; Tsai SL
J Biomed Sci; 2007 Jan; 14(1):43-57. PubMed ID: 17109186
[TBL] [Abstract][Full Text] [Related]
2. Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion.
Tsai SL; Chen PJ; Lai MY; Yang PM; Sung JL; Huang JH; Hwang LH; Chang TH; Chen DS
J Clin Invest; 1992 Jan; 89(1):87-96. PubMed ID: 1729285
[TBL] [Abstract][Full Text] [Related]
3. Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection.
Stoop JN; van der Molen RG; Baan CC; van der Laan LJ; Kuipers EJ; Kusters JG; Janssen HL
Hepatology; 2005 Apr; 41(4):771-8. PubMed ID: 15791617
[TBL] [Abstract][Full Text] [Related]
4. [Dendritic cells originated from the peripheral blood in chronic hepatitis B patients can induce specific T cell immune response].
Li RB; Chen HS; Xie Y; Fei R; Cong X; Fan CL; Wang SX; Wei L; Wang Y
Zhonghua Gan Zang Bing Za Zhi; 2003 Oct; 11(10):588-91. PubMed ID: 14572332
[TBL] [Abstract][Full Text] [Related]
5. Extrathymic expression of the intracellular hepatitis B core antigen results in T cell tolerance in transgenic mice.
Milich DR; Jones JE; Hughes JL; Maruyama T; Price J; Melhado I; Jirik F
J Immunol; 1994 Jan; 152(2):455-66. PubMed ID: 8283030
[TBL] [Abstract][Full Text] [Related]
6. [Detection of HBcAg-specific cytotoxic lymphocytes and their association with clinical status in patients with hepatitis B].
Fan ZP; Wang FS; Xu DP; Chu FL; Shi M; Zhou Y; Zhang LX
Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(24):2073-6. PubMed ID: 15730619
[TBL] [Abstract][Full Text] [Related]
7. Association of CD4+CD25+Foxp3+ regulatory T cells with chronic activity and viral clearance in patients with hepatitis B.
Yang G; Liu A; Xie Q; Guo TB; Wan B; Zhou B; Zhang JZ
Int Immunol; 2007 Feb; 19(2):133-40. PubMed ID: 17182968
[TBL] [Abstract][Full Text] [Related]
8. Intrahepatic, nucleocapsid antigen-specific T cells in chronic active hepatitis B.
Ferrari C; Penna A; Giuberti T; Tong MJ; Ribera E; Fiaccadori F; Chisari FV
J Immunol; 1987 Sep; 139(6):2050-8. PubMed ID: 2957446
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B core antigen is a potent inductor of interleukin-18 in peripheral blood mononuclear cells of healthy controls and patients with hepatitis B infection.
Manigold T; Böcker U; Chen J; Gundt J; Traber P; Singer MV; Rossol S
J Med Virol; 2003 Sep; 71(1):31-40. PubMed ID: 12858406
[TBL] [Abstract][Full Text] [Related]
10. Interferon-gamma production specific for hepatitis B virus antigen by intrahepatic T lymphocytes in patients with acute and chronic hepatitis B.
Kakumu S; Ishikawa T; Wakita T; Yoshioka K; Takayanagi M; Tahara H; Kusakabe A
Am J Gastroenterol; 1994 Jan; 89(1):92-6. PubMed ID: 8273806
[TBL] [Abstract][Full Text] [Related]
11. [Changes of antigen-specific cytotoxic T lymphocytes during acute flare-ups in chronic hepatitis B patients].
Deng H; Chong YT; Han XY; Zhang FC; Peng XM; Gao ZL; Yao JL
Zhonghua Gan Zang Bing Za Zhi; 2006 Oct; 14(10):721-4. PubMed ID: 17064461
[TBL] [Abstract][Full Text] [Related]
12. Difference in T helper responses during hepatitis flares in hepatitis B e antigen (HBeAg)-positive patients with genotypes B and C: implication for early HBeAg seroconversion.
Yuen MF; Wong DK; Zheng BJ; Chan CC; Yuen JC; Wong BC; Lai CL
J Viral Hepat; 2007 Apr; 14(4):269-75. PubMed ID: 17381719
[TBL] [Abstract][Full Text] [Related]
13. Characterization of T-cell tolerance to hepatitis B virus (HBV) antigen in transgenic mice.
Takashima H; Araki K; Miyazaki J; Yamamura K; Kimoto M
Immunology; 1992 Mar; 75(3):398-405. PubMed ID: 1533387
[TBL] [Abstract][Full Text] [Related]
14. Modulation of the CD8+-T-cell response by CD4+ CD25+ regulatory T cells in patients with hepatitis B virus infection.
Franzese O; Kennedy PT; Gehring AJ; Gotto J; Williams R; Maini MK; Bertoletti A
J Virol; 2005 Mar; 79(6):3322-8. PubMed ID: 15731226
[TBL] [Abstract][Full Text] [Related]
15. In vivo inhibition of anti-hepatitis B virus core antigen (HBcAg) immunoglobulin G production by HBcAg-specific CD4(+) Th1-type T-cell clones in a hu-PBL-NOD/SCID mouse model.
Cao T; Meuleman P; Desombere I; Sällberg M; Leroux-Roels G
J Virol; 2001 Dec; 75(23):11449-56. PubMed ID: 11689626
[TBL] [Abstract][Full Text] [Related]
16. Proliferative and cytotoxic T-cell clones recognize endogenously synthesized HBcAg in an asymptomatic HBsAg carrier.
Shu PY; Chang C; Hwang LH; Hu CP
Hepatology; 1993 Aug; 18(2):275-83. PubMed ID: 7687980
[TBL] [Abstract][Full Text] [Related]
17. Distinction between immunogenicity and tolerogenicity among HBcAg T cell determinants. Influence of peptide-MHC interaction.
Milich DR; Jones JE; McLachlan A; Houghten R; Thornton GB; Hughes JL
J Immunol; 1989 Nov; 143(10):3148-56. PubMed ID: 2478619
[TBL] [Abstract][Full Text] [Related]
18. Comparative immunogenicity of hepatitis B virus core and E antigens.
Milich DR; McLachlan A; Stahl S; Wingfield P; Thornton GB; Hughes JL; Jones JE
J Immunol; 1988 Nov; 141(10):3617-24. PubMed ID: 2460543
[TBL] [Abstract][Full Text] [Related]
19. Vaccination against hepatitis B in liver transplant recipients: pilot analysis of cellular immune response shows evidence of HBsAg-specific regulatory T cells.
Bauer T; Günther M; Bienzle U; Neuhaus R; Jilg W
Liver Transpl; 2007 Mar; 13(3):434-42. PubMed ID: 17318860
[TBL] [Abstract][Full Text] [Related]
20. Effect of IL-18 on peripheral blood mononuclear cells of chronic hepatitis B and hepatitis B virus DNA released by HepG2.2.15 cell lines.
Sun Y; Chen HY; Xin SJ
Hepatobiliary Pancreat Dis Int; 2004 May; 3(2):230-4. PubMed ID: 15138116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
